Drugs / Triptolide
Triptolide
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01817283 | Jan 2013 → Jul 2014 | HIV infectious disease | LI Taisheng | Unknown | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT02219672 | Jul 2014 → Jul 2016 | AIDS | Peking Union Medical College | Unknown | No outcome recorded |
| Phase 3 | NCT02115659 | Apr 2014 → May 2016 | autosomal dominant polycystic kidney disease | Shanghai Changzheng Hospital | Unknown | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Triptolide | “Drug: Triptolide Triptolide Wilfordii is a Chinese old herb” NCT02219672 ↗ |
| Known as | NSC-163062 | ChEMBL registry synonym — accepted as the source's own label CHEMBL463763 ↗ |
| Known as | Tripterygium Wilfordii Hook F (TwHF) | “Other Name: Tripterygium Wilfordii Hook F (TwHF)” NCT02219672 ↗ |
| Known as | Triptolide Wilfordii | “Triptolide Wilfordii is a Chinese old herb which is widely used as a remedy for rheumatic diseases and nephropathy in China.” NCT01817283 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Triptolide Wilfordii is a Chinese old herb” NCT01817283 ↗ |
| Route | Oral | “Triptolide wilfordii (20mg tid po) would be given to invention group for 24 weeks.” NCT01817283 ↗ |